PeakedLabs Research Series · Ebook + workbook
Understand the evidence, the provider, and the full cost before you choose peptide therapy.
Make sense of approved medicines and experimental claims. Compare the care you will receive, verify the pharmacy behind the brand, and work through the full annual cost with practical examples and eight worksheets you can bring to an appointment.
- Length
- 69 pages, 13 chapters
- Format
- PDF + printable workbook
- Edition
- September 2026
One-time purchase. 69-page ebook and eight-page workbook. Secure checkout via Stripe.
No email needed for the web excerpt or original three-page PDF. Browse all 13 chapters below.
What's inside
Thirteen chapters, eight practical worksheets
Read in order or jump straight to the worksheets: the guide is built to be carried into a clinician appointment, not just read once.
- 01
Start with a decision, not a molecule
Define the outcome that matters, compare alternatives, and write a useful decision brief.
- 02
Read the evidence without becoming a scientist
Interpret trial results, absolute versus relative effects, surrogate markers and population differences.
- 03
The US regulatory map
Separate approved products, off-label use, compounding, investigational treatments and research-use-only materials.
- 04
GLP-1 medicines
Compare current oral and injectable options, landmark trials, maintenance and practical access questions.
- 05
Growth-hormone claims and the TRT boundary
Understand tesamorelin, CJC-1295, ipamorelin and testosterone through their distinct evidence and indications.
- 06
Injury and recovery peptides
Examine BPC-157, TB-500, KPV, MOTs-C and AOD-9604 claims against the research that actually supports them.
- 07
Sexual health, sleep, cognition, skin and longevity
A goal-by-goal look at PT-141, DSIP, Selank, Semax, epitalon and GHK-Cu.
- 08
Baseline assessment and monitoring
Ask which clinical question each test answers and agree on who reviews results and what changes the plan.
- 09
Prescription literacy
Recognize conflicting product instructions, formulation changes, storage questions and continuity gaps.
- 10
Adverse events and next actions
Distinguish emergency help, prompt assessment, routine follow-up and product-quality reporting.
- 11
Verify the provider, pharmacy and product
Check licenses, dispensing arrangements, compounding claims, COA limitations, records and cancellation terms.
- 12
Calculate the real annual cost
Three worked examples cover promotional pricing, insurance changes and 28-day versus calendar-month billing.
- 13
A useful clinician conversation
Use decision scripts, follow-up examples and eight printable worksheets to put the research to work.
69 pages · 59 linked sources · eight worksheets · $29 once.
Use one worksheet before you try to finish all eight.
Start with “My decision brief”: describe the question you want help with, what matters to you and what is still unanswered. Use the evidence worksheet to separate what a source supports from what it does not establish. The appointment sheet records who reviews the agreed follow-up and when; the renewal sheet brings the original goal back into the conversation. These are printable note pages, not an online assessment or personalized recommendation.
The free three-page sample contains the cover, contents and a hypothetical cost comparison. The $29 bundle contains the full research ebook and all eight printable worksheets.
Read how to use the decision workbookFrom Chapter 12 · Calculate the real annual cost
Free sample excerpt · hypothetical cost comparison
Selected text and figures from the public three-page sample. The unchanged PDF includes the cover, contents and cost example. September 5, 2026 research edition.
- Initial evaluation
ClearPath, hypothetical
$125
ReadyCare, hypothetical
$0
- Membership
ClearPath, hypothetical
$95 × 12 = $1,140
ReadyCare, hypothetical
$145 × 12 = $1,740
- Medication
ClearPath, hypothetical
$320 × 12 = $3,840
ReadyCare, hypothetical
$285 × 3 + $385 × 9 = $4,320
- Agreed laboratory costs
ClearPath, hypothetical
$180 × 2 = $360
ReadyCare, hypothetical
$240 + $120 = $360
- Additional billed follow-ups
ClearPath, hypothetical
Included
ReadyCare, hypothetical
$65 × 2 = $130
- Shipping
ClearPath, hypothetical
Included
ReadyCare, hypothetical
$15 × 12 = $180
- Required supplies
ClearPath, hypothetical
Included
ReadyCare, hypothetical
Included
- Total year-one cost
ClearPath, hypothetical
$5,465
ReadyCare, hypothetical
$6,730
- Average per calendar month
ClearPath, hypothetical
$455.42
ReadyCare, hypothetical
$560.83
The conclusion is not “always choose ClearPath.” If ReadyCare provides a clinically important service that ClearPath lacks, the difference may be worth discussing. The point is that you now know the amount you are comparing rather than mistaking a promotional medication price for an annual care budget.
“A spreadsheet cannot fix a mismatched comparison. First compare appropriate options; then compare the money.”Open the original three-page sample (PDF)
Buy it if
This guide earns its price when
- You are evaluating peptide therapy with a licensed clinician and want the homework done before the consultation.
- You are already receiving care and want better questions about monitoring, changing pharmacies, follow-up and renewal costs.
- You are comparing clinics and want to pressure-test their pricing, lab requirements, and refill terms with specific questions.
Skip it if
Save your $29 when
- You want sourcing shortcuts for research chemicals without clinician oversight. The guide argues directly against that.
- You want a promise of results. The evidence for several popular peptides is preclinical or mixed, and the guide says so compound by compound.
- You are a clinician looking for a primary-literature review. This is a structured decision guide for patients, with references — not a meta-analysis.
Questions
Before you buy
- Price
- $29, one-time
- Format
- 69-page PDF
- Delivery
- Download after confirmed payment
- Edition
- September 5, 2026
Is this medical advice?
No. This is educational research for adults preparing a clinician conversation. It discloses AI research assistance and has not undergone independent licensed physician or pharmacist review. No medical-review credentials are claimed.
Which peptides does it actually cover?
GLP-1 medicines and compounds including BPC-157, TB-500, CJC-1295, ipamorelin, tesamorelin, AOD-9604, KPV, MOTs-C, DSIP, epitalon, PT-141 and GHK-Cu. Each category is discussed with its own evidence and product-status limits.
Does it cover GLP-1s like semaglutide?
Yes. The September edition adds a full GLP-1 chapter covering current approved options, trial interpretation, oral versus injectable treatment, maintenance and access questions.
I'm already on a protocol. Is it still useful?
Chapters 8–13 cover monitoring questions, prescription literacy, adverse events, provider verification, annual costs and renewal decisions. The workbook includes an appointment agreement and follow-up record.
How is this different from your free articles?
The blog covers individual topics. The ebook connects the evidence, product status, provider checks and full costs in one place, with three worked cost examples and eight worksheets. A separate printable workbook is included.
How do I get it, and how current is it?
Checkout runs through Stripe. After payment is confirmed, the purchase page provides instant ebook and workbook downloads. Save both PDFs and bookmark the private purchase-page link for later access; do not share that link. The research cutoff is September 5, 2026. Existing verified buyers can use their purchase link to get the updated edition.
The newsletter
Not ready to buy yet?
Get the free provider decision toolkit — cost tools, comparison questions and research updates. The paid ebook is a separate purchase.
Free forever. Unsubscribe anytime. We never sell your email.
Make your next provider conversation more useful. Bring the evidence, the questions, and a realistic budget.
This guide is for educational purposes only and is not medical advice, diagnosis, or treatment. It does not establish a clinician-patient relationship. Several peptides discussed are not FDA-approved for general human use. Always review options with a licensed clinician who can evaluate your history, medications, labs, and risk profile.